Per a court order, HHS is required to restore this website to its version as of 12:00 AM on January 29, 2025. Information on this page may be modified and/or removed in the future subject to the terms of the court’s order and implemented consistent with applicable law. Any information on this page promoting gender ideology is extremely inaccurate and disconnected from truth. The Trump Administration rejects gender ideology due to the harms and divisiveness it causes. This page does not reflect reality and therefore the Administration and this Department reject it.

U.S. Department of Health and Human Services Office of Disease Prevention and Health Promotion

Pharmacologic Interventions for Pregnant Women Enrolled in Alcohol Treatment

About this resource:

Systematic Review

Source: The Cochrane Collaborative

Last Reviewed: July 2009

Workgroups: Substance Use Workgroup, Maternal, Infant, and Child Health Workgroup

In this Cochrane systematic review, the Cochrane Collaborative could not determine the effectiveness of using medicines to treat pregnant people with alcohol dependence enrolled in alcohol treatment programs. In these interventions, pregnant people take medicine to help them detoxify from alcohol by reducing withdrawal symptoms. Researchers didn’t find answers to their questions because there were no relevant randomized controlled trials. They noted that because of stigma related to alcohol use in pregnancy, recruiting for studies in this population is likely to remain difficult.

Read more about this resource

Objectives related to this resource (1)

Reduce the proportion of people who had alcohol use disorder in the past year — SU‑13
Little or no detectable change

Suggested Citation

1.

Smith, E.J., Lui, S. & Terplan, M. (2009). Pharmacologic Interventions for Pregnant Women Enrolled in Alcohol Treatment. Cochrane Database of Systematic Reviews, 2009 (3). DOI: 10.1002/14651858.CD007361.pub2.